What does RGNXE mean in NASDAQ SYMBOLS
RGNXE is the stock symbol for Regenex, Inc., a biopharmaceutical company based in San Diego that focuses on the development and commercialization of innovative therapeutics to address unmet needs in the treatment of neurological and degenerative diseases. Founded in 2009, Regenex is dedicated to finding new drug therapies and treatments for patients suffering from debilitating diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Parkinson’s disease, traumatic brain injury (TBI) and stroke.
RGNXE meaning in NASDAQ Symbols in Business
RGNXE mostly used in an acronym NASDAQ Symbols in Category Business that means Regenex, Inc.
Shorthand: RGNXE,
Full Form: Regenex, Inc.
For more information of "Regenex, Inc.", see the section below.
What RGNXE means
RGNXE stands for Regenex, Inc., which is an American biopharmaceutical company with headquarters located in San Diego, California. The company focuses primarily on developing and commercializing innovative therapeutic treatments and drugs for neurological and degenerative diseases such as ALS (amyotrophic lateral sclerosis), Alzheimer's disease, Parkinson's disease, TBI (traumatic brain injury) and stroke. The company has developed several clinical products that have gone through rigorous trials to support their efficacy before being released into the market.
Overall Meaning
RGNXE stands for Regenex Inc., a biopharmaceutical company based in San Diego that specializes in developing innovative therapeutic treatments for neurological and degenerative diseases. As a publicly traded company it has been listed on the NASDAQ since its inception in 2009. The goal of the company is to provide better care for those suffering from these conditions by researching potential therapies that can help improve current treatments. Through its efforts to develop groundbreaking medications, Regenex continues to strive for better health outcomes for those affected by neurological or degenerative diseases throughout the world.
Essential Questions and Answers on Regenex, Inc. in "BUSINESS»NASDAQ"
What is Regenex?
Regenex is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for the treatment of serious and life-threatening diseases.
How does Regenex work?
Regenex is committed to leveraging its unique platform technologies to design and develop proteins and nucleic acid-based therapeutics that modulate biological pathways to restore lost or impaired function in chronically or acutely ill patients.
Is Regenex publicly traded?
Yes, Regenex is publicly traded on the NYSE American under the symbol “RGNX”.
Does Regenex have a Board of Directors?
Yes. Our Board of Directors consists of experienced leaders in the biotechnology industry who share their expertise and knowledge to help guide us in our mission.
What therapeutic areas does Regenex focus on?
We are focused on developing therapies to treat serious conditions such as neurodegenerative disease, cancer, metabolic disorders, autoimmune disorders and rare diseases.
Where can I find more information about RGNX stock?
Investors can find more information about RGNX stock on our investor relations website at https://ir.regenxinc.com/.
What clinical programs is Regenex currently working on?
We currently have three programs in clinical development – RGX-121 for Friedreich's Ataxia; RGX-314 for wet age-related macular degeneration; and RGX-501 for asthma – with additional programs expected to enter clinical development later this year.